Dronabinol Therapy: Central Nervous System Adverse Events in Adults With Primary Brain Tumors.

Dronabinol Therapy: Central Nervous System Adverse Events in Adults With Primary Brain Tumors.
Clin J Oncol Nurs. 2019 Feb 01;23(1):23-26
Authors: Allen D
Abstract
Dronabinol is an effective adjunct to antiemetic regimens during cancer treatment in several populations of patients with cancer. However, it has been used little in central nervous system (CNS) cancers because of concerns regarding potential CNS adverse events. This secondary analysis explored CNS adverse events reported by adults with primary brain tumors while receiving dronabinol during chemotherapy. The occurrence of CNS adverse events in this population was similar to that reported by patients in other oncology populations.
PMID: 30681988 [PubMed - in process]

Source: Clinical Journal of Oncology Nursing - January 27, 2019 Category: Nursing Authors: Allen D Tags: Clin J Oncol Nurs Source Type: research